Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro

A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding

1976 • 225,752 citations

Molecular cloning: A laboratory manual

1990 • 85,659 citations

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1984 • 6,841 citations

Promotion of microtubule assembly in vitro by taxol

1979 • 3,521 citations

What is synergy?

1989 • 1,315 citations

Isolation and Characterization of Full-Length cDNA Clones for Human α-, β-, and γ-Actin mRNAs: Skeletal but Not Cytoplasmic Actins Have an Amino-Terminal Cysteine that Is Subsequently Removed

1983 • 1,220 citations

Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms

1989 • 1,111 citations

Taxol: A Novel Investigational Antimicrotubule Agent

1990 • 1,084 citations

MATHEMATICAL ANALYSIS OF DNA DISTRIBUTIONS DERIVED FROM FLOW MICROFLUOROMETRY

1974 • 795 citations

Human metallothionein genes—primary structure of the metallothionein-II gene and a related processed gene

1982 • 464 citations

Phase I clinical and pharmacokinetic study of taxol.

1987 • 449 citations

Sequences of taxol and cisplatin: a phase I and pharmacologic study.

1991 • 438 citations

Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance.

1990 • 393 citations

Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells

1990 • 357 citations

Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma.

1987 • 286 citations

Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion.

1985 • 195 citations

Cell-mediated immunity to human malignant cells

1972 • 148 citations

Phenotypic consequences of tubulin overproduction in Saccharomyces cerevisiae: differences between alpha-tubulin and beta-tubulin.

1990 • 131 citations

Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cells

1991 • 93 citations

Flow cytometric discrimination of mitotic cells: Resolution of M, as well as G₁, S, and G₂ phase nuclei with mithramycin, propidium iodide, and ethidium bromide after fixation with formaldehyde

1986 • 89 citations

Recognition of cells in mitosis by flow cytofluormetry.

1977 • 57 citations

In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

1993 • 54 citations

Phenotypic Consequences of Tubulin Overproduction in Saccharomyces cerevisiae: Differences between Alpha-Tubulin and Beta-Tubulin

1990 • 48 citations

Synergistic enhancement of the antiproliferative activity ofcis‐diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase C

1989 • 47 citations

Interphase and metaphase chromatin

1977 • 41 citations

In vitro mechanism study of microtubule assembly inhibition by cis-dichlorodiammine-platinum(II)

1986 • 36 citations

Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells.

1990 • 35 citations

Agarose Gel Electrophoresis

1986 • 35 citations

Synergism between dipyridamole and cisplatin in human ovarian carcinoma cells in vitro.

1992 • 30 citations

The mutagenic and carcinogenic properties of three second generation antitumour platinum compounds: a comparison with cisplatin

1989 • 30 citations

Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer

1991 • 22 citations

Morphological studies on the effect of taxol on cultured human prostatic cancer cells

1987 • 21 citations

Dipyridamole-Cisplatin Potentiation: Enhanced in Vivo Cytotoxicity in Xenograft Models of Human Testicular and Bladder Cancers

1990 • 21 citations

REPAIR OF cis-PLATINUM (II) DIAMMINE DICHLORIDE-INDUCED DNA DAMAGE AND CELL SENSITIVITY

1980 • 20 citations

Reduced cellular uptake of cis-dichlorodiammine-platinum by benzaldehyde.

1986 • 19 citations

Protection from cis-dichlorodiammineplatinum-induced cell inactivation by aldehydes involves cell membrane amino groups

1985 • 16 citations

Combination chemotherapy tested in a short‐term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas

1992 • 5 citations